Now showing items 1-2 of 2

  • Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer 

    Macherla, Shravanti; Laks, Shachar; Naqash, Abdul Rafeh; Bulumulle, Anushi; Zervos, Emmanuel; Muzaffar, Mahvish (2018-11-07)
    Immune checkpoint blockade (ICB) with programmed cell death protein-1(PD-1)/programmed death ligand -1(PD-L1) antibodies has revolutionized the management of several cancers, especially non-small cell lung cancer, melanoma, ...
  • Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition 

    Naqash, Abdul Rafeh; Appah, Ebenezer; Yang, Li V.; Muzaffar, Mahvish; Marie, Mona A.; Mccallen, Justin D.; Macherla, Shravanti; Liles, Darla; Walker, Paul R. (2019-07-05)
    Background Compared to conventional chemotherapy, Immune checkpoint inhibitors (ICI) are known to have a distinct toxicity profile commonly identified as immune-related adverse events (irAEs). These irAEs that are believed ...